3Pinto RJ, Dalvi BV, Sharma S. Transcatheter closure of perimembra?nous ventricular septal defects using Amplatzer asymmetric ventricular septal defect occluder , preliminary experience with 18 -month follow up. Catheter Cardiovasc Interv ,2006,68: 145-152.
4Guo QK, Lu ZQ, Cheng SF, et al. Off-pump occlusion of trans-tho?racic minimal invasive surgery (OPOTTMIS) on simple congenital heart diseases (ASD, VSD and PDA) attached consecutive 210 ca?ses report: a single institute experience.J Cardiothorac Surg, 2011 , 6:48.
6Yalonetsky S, Lorber A. Left ventricular segmental dysfunction fol?lowing percutaneous transcatheter closure of a membranous ventricular septal defect. Catheter Cardiovasc Interv ,2007, 69: 590 - 592.
7Kurosawa H, Imai Y. Surgical anatomy of the atrioventricular bundle in tetralogy of Fallo!. New findings relevant to the position of the su?tures.J Thorac Cardiovasc Surg, 1988,95 :586-591.
8Fischer G, Apostolopoulou SC, Rammos S, et al. The Amplatzer Membranous VSD Occluder and the vulnerability of the atrioventricu?lar conduction system Cardiol Young, 2007 ,17 : 499-504.
9Walsh MA, BialkoskiJ, Szkutnik M, et al. Atrioventricular block after transcatheter closure. of perimembranous ventricular septal de?fects. Heart, 2006,92:1295-1297.
10Wertman B, Azarbal B, Riedl M, et al. Adverse events associated with nickel allergy in patients undergoing percutaneous atrial septal defect or patent foramen ovale closure.J Am Coli Cardiol, 2006,47: 1226-1227.
